EAU 2013 - Programme Book - YouMed

Saturday
Saturday, 16 March - EAU Programme
134 Programme Book
Abstract Session
16.00 - 17.30 Improving diagnosis in prostate cancer
Silver Hall - Level N2
Poster Session 19
Chairs: P. Macek, Prague (CZ)
M.P. Matikainen, Helsinki (FI)
Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes
in length, followed by 2 minutes for discussion. Extended presentations (*) are 4 minutes in length, followed
by 2 minutes for discussion.
217 Structured reporting of multiparametric MRI in detecting prostate cancer: Accuracy and inter-observer
variability
R. Van Soest, R.S. Dwarkasing, G.J.L.H. Van Leenders, H.J. Teertstra, P. De Koekkoek, S.W.T.P. Heijmink,
M. Wildhagen, H.G. Van Der Poel, E.W. Steyerberg, C.H. Bangma (Rotterdam, Amsterdam, The Netherlands)
218 Association of level of suspicion of prostate cancer on multi-parametric MRI with detection rate of prostate
cancer
V. Kasivisvanathan, R. Dufour, C.M. Moore, H.U. Ahmed, M.A. Abd-Alazeez, S. Charman, A. Freeman,
A. Kirkham, C. Allen, J. Van Der Meulen, M. Emberton (London, United Kingdom)
* 219 Diagnostic accuracy of multiparametric MRI in detection of clinically significant prostate cancer
F. Porpiglia, C. Fiori, F. Mele, M. Manfredi, R. Bertolo, S. Grande, M. Poggio, D. Garrou, G. Cattaneo,
E. Bollito, M. Papotti, F. Russo, D. Regge (Orbassano (Turin), Candiolo (Turin), Italy)
220 Initial experience of 200 men undergoing 3 dimensional ultrasound prostate biopsy in analysis between
systematic and MR-fusion biopsy
A. Marien, A. Villers, S. Palmer, S. Leslie, H. Ahmadi, A.L. De Castro Abreu, S. Shoji, M. Aron, M.M. Desai,
I.S. Gill, O. Ukimura (Los Angeles, United States of America; Lille, France)
221 Diagnosis of anterior prostate cancer using MRI/TRUS soft image fusion
E. Baco, E. Rud, D. Klotz, H.B. Eggesbø (Oslo, Norway)
* 222 Detecting clinically significant prostate cancer by MRI-targeted TRUS-guided transperineal fusion biopsy
T.H. Kuru, M. Roethke, T. Simpfendoerfer, S. Boxler, J. Seidenader, H-P. Schlemmer, M. Hohenfellner,
B. Hadaschik (Heidelberg, Germany)
223 Objective differentiation of prostate cancer from normal prostate tissue: Diagnostic usefulness of
discriminant analysis of T2 and diffusion-weighted MR imaging
R. Nemoto (Tottori, Japan)
* 224 Incremental benefit of 3T diffusion weighted MRI for pre-operative prostate cancer staging: A prospective
dual reader study
E.M. Lawrence, F.A. Gallagher, T. Barrett, A. Warren, A.N. Priest, E. Sala, V.J. Gnanapragasam (Cambridge,
United Kingdom; Toronto, Canada; New York, United States of America)
225 Identification of patient subgroups with the highest benefit from real-time-sonoelastography (RTE)
targeted biopsy of the prostate
J. Bründl, H-M. Fritsche, M. Gierth, A. Brandtner, W.F. Wieland, R. Ganzer (Regensburg, Germany)